X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (41334) 41334
Newsletter (7429) 7429
Newspaper Article (2890) 2890
Book Chapter (214) 214
Transcript (164) 164
Magazine Article (130) 130
Reference (52) 52
Dissertation (48) 48
Book / eBook (47) 47
Publication (23) 23
Web Resource (11) 11
Streaming Video (7) 7
Conference Proceeding (6) 6
Journal / eJournal (4) 4
Trade Publication Article (3) 3
Book Review (2) 2
Government Document (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26704) 26704
non-hodgkin's lymphomas (22153) 22153
male (14797) 14797
female (14326) 14326
non-hodgkins-lymphoma (14287) 14287
oncology (13298) 13298
middle aged (12214) 12214
cancer (11902) 11902
adult (10765) 10765
aged (10064) 10064
hematology (9503) 9503
research (8414) 8414
lymphomas (7810) 7810
chemotherapy (7501) 7501
t cells (7406) 7406
care and treatment (6584) 6584
prognosis (5481) 5481
non-hodgkin's lymphoma (5476) 5476
lymphoma (5397) 5397
antineoplastic combined chemotherapy protocols - therapeutic use (4164) 4164
aged, 80 and over (4128) 4128
adolescent (4050) 4050
non-hodgkin lymphoma (3957) 3957
treatment outcome (3899) 3899
rituximab (3738) 3738
leukemia (3534) 3534
health aspects (3533) 3533
risk factors (3461) 3461
b-cell lymphoma (3374) 3374
analysis (3267) 3267
pathology (3256) 3256
non-hodgkin-lymphoma (3235) 3235
diagnosis (3191) 3191
retrospective studies (3108) 3108
medical research (2935) 2935
transplantation (2880) 2880
therapy (2790) 2790
animals (2736) 2736
disease (2670) 2670
medicine, experimental (2505) 2505
lymphoma, non-hodgkin - pathology (2494) 2494
child (2490) 2490
tumors (2464) 2464
drug therapy (2462) 2462
survival (2429) 2429
immunohistochemistry (2395) 2395
hemic and lymphatic diseases (2389) 2389
genetic aspects (2295) 2295
expression (2281) 2281
lymphoma, non-hodgkin - drug therapy (2231) 2231
immunology (2211) 2211
medicine & public health (2141) 2141
follicular lymphoma (2054) 2054
neoplasm staging (2016) 2016
physical fitness (1985) 1985
young adult (1981) 1981
antineoplastic agents - therapeutic use (1927) 1927
chronic lymphocytic-leukemia (1914) 1914
antineoplastic agents (1899) 1899
classification (1864) 1864
disease-free survival (1864) 1864
malignant-lymphoma (1846) 1846
survival rate (1834) 1834
survival analysis (1816) 1816
non-hodgkins-lymphomas (1808) 1808
risk (1804) 1804
antimitotic agents (1802) 1802
universities and colleges (1802) 1802
combined modality therapy (1794) 1794
oncology, experimental (1769) 1769
immunotherapy (1737) 1737
apoptosis (1709) 1709
cyclophosphamide - administration & dosage (1675) 1675
follow-up studies (1661) 1661
radiotherapy (1659) 1659
lymphoma, large b-cell, diffuse - pathology (1645) 1645
epidemiology (1641) 1641
clinical trials (1638) 1638
medicine, general & internal (1587) 1587
stem cells (1586) 1586
patients (1573) 1573
radiology, nuclear medicine & medical imaging (1551) 1551
lymphoma, non-hodgkin - therapy (1481) 1481
child, preschool (1439) 1439
development and progression (1429) 1429
surgery (1428) 1428
vincristine - administration & dosage (1427) 1427
biopsy (1419) 1419
lymphoma, b-cell - pathology (1410) 1410
pharmaceutical industry (1403) 1403
immune system diseases (1391) 1391
lymphoma, large b-cell, diffuse - drug therapy (1369) 1369
non-hodgkins lymphoma (1367) 1367
doxorubicin - administration & dosage (1365) 1365
diagnosis, differential (1364) 1364
antineoplastic combined chemotherapy protocols - administration & dosage (1332) 1332
cyclophosphamide (1317) 1317
mice (1295) 1295
incidence (1248) 1248
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49904) 49904
Japanese (673) 673
French (470) 470
German (466) 466
Chinese (321) 321
Spanish (258) 258
Russian (132) 132
Polish (72) 72
Turkish (51) 51
Portuguese (41) 41
Italian (32) 32
Czech (29) 29
Hungarian (16) 16
Korean (16) 16
Persian (8) 8
Dutch (3) 3
Slovak (3) 3
Slovenian (3) 3
Croatian (2) 2
Arabic (1) 1
Catalan (1) 1
Greek (1) 1
Manx (1) 1
Romanian (1) 1
Serbian (1) 1
Thai (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Haematology, ISSN 0007-1048, 02/2007, Volume 136, Issue 3, pp. 439 - 447
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2009, Volume 145, Issue 3, pp. 344 - 349
Journal Article
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 06/2019, Volume 104, Issue 6, pp. 1202 - 1208
We evaluated early disease progression and its impact on overall survival (OS) in previously untreated follicular lymphoma patients in GALLIUM ( ), and... 
Journal Article
Nature medicine, ISSN 1546-170X, 2018, Volume 24, Issue 5, pp. 679 - 690
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 7, p. e41658
Background: Recent research has shown a correlation between immune microenvironment and lymphoma biology. This study aims to investigate the prognostic... 
SURVIVAL | LYMPHOPENIA | ABSOLUTE MONOCYTE | PROGNOSTIC-FACTOR | RESPONSE CRITERIA | MULTIDISCIPLINARY SCIENCES | TUMOR | NON-HODGKIN-LYMPHOMA | COUNT | EXPRESSION | CHEMOTHERAPY | Doxorubicin - therapeutic use | Multivariate Analysis | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prognosis | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Treatment Outcome | Cyclophosphamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - diagnosis | Lymphoma, Large B-Cell, Diffuse - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Monocytes - pathology | Vincristine - therapeutic use | Female | ROC Curve | Aged | Leukocyte Count | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Care and treatment | Anthracyclines | Cyclophosphamide | Corticosteroids | Lymphocytes | Prednisone | Non-Hodgkin's lymphomas | Therapy | Working groups | Laboratories | Cytotoxicity | Oncology | Multivariate analysis | Cancer therapies | Doxorubicin | Training | Bioindicators | Neutropenia | Risk groups | Cut-off | Melanoma | Rituximab | Data processing | Risk analysis | Gene expression | Survival | Patients | Vincristine | Lymphoma | Survival analysis | Chemotherapy | Monocytes | Lymphocytes B | Medical prognosis | Biomarkers | Lymphomas | Apoptosis | B-cell lymphoma
Journal Article